Central Nervous System Lymphomas (Ongoing)

Posted On 2020-09-28 09:33:41



Evidence on the diagnosis and treatment of patients with CNS lymphomas as well asour knowledge in the biological and molecular profiles of this disease grew very fastin the latest years, and contribution of experts is important to put in context reportedstudies, draw recommendations and delineate future research. We feel it is important to dedicate a special issue on Central Nervous System Lymphomas and aim to provide an updated overview of the most recent acquisitions and future perspectives.

Dr. Andrés J. M. Ferreri had a degree in Medicine in the Facultad de Medicina of the Universidad de Buenos Aires, Argentina in 1985, and obtained the degree of Doctor in Medicine and Surgery in the Facoltà di Medicina e Chirurgia dell’Università degli Studi di Parma, Italy, in 1992. He is Specialist in Clinical Oncology (Università degli Studi di Milan, Italy, 2005). He was research fellow at the Divisione di Oncologia Sperimentale “E” and at the Divisione di Oncologia Médica “A” of the Istituto Nazionale dei Tumori of Milan (1989–1994) and vice-director of the Medical Oncology Unit of the San Raffaele Scientific Institute of Milan, Italy. Currently, Dr. Ferreri is Contract Professor of Oncology at the University Vita-Salute San Raffaele of Milan, Vice-Director of the Unit of Onco-Hematological Medicine and Director of the Lymphoma Unit at the IRCCS San Raffaele Scientific Institute, Milan; Deputy President of the Fondazione Italiana Linfomi (FIL) and Member of the Board of Directors of The International Extranodal Lymphoma Study Group (IELSG).

Dr. Ferreri is fully devoted to the research on non-Hodgkin lymphomas, is an opinion leader in the field of extranodal lymphomas.

Dr. Ponzoni is the Full Professor of Pathology at Ateneo-Vita-Salute San Raffaele University in Milan, Italy. He obtained his MD degree and Board of Pathology from University of Milan. He spent part of his formation in Mayo Clinic, Rochester, MN, USA and New York University Medical Centre, New York, NY, USA. He is the Coordinator of the Haematopathology within the Pathology Unit of Ospedale San Raffaele Scientific Institute. Dr. Ponzoni is author of more than 340 papers focused on Haematopathology available on PUBMED. He is active member of National and International Groups investigating hematological malignancies.

Series outline:

  1. Primary CNS Lymphoma: Epidemiology and Clinical Presentation
  2. Primary CNS Lymphoma: Old and New Concepts in Neuroimaging
  3. PET Imaging in Primary CNS Lymphoma
  4. Primary CNS Lymphoma: Biomarkers and Early Diagnosis
  5. Histopathological Diagnosis of Primary CNS Lymphoma
  6. Primary CNS Lymphoma: Molecular and Biogical Features of Neoplastic Cells
  7. Primary CNS Lymphoma: Molecular and Biogical Features of Microenvironment Components
  8. Primary CNS Lymphoma: Induction Chemoimmunotherapy
  9. Primary CNS Lymphoma: Consolidation Strategies
  10. Primary CNS Lymphoma: Maintenance Strategies
  11. Treatment of Elderly Patients with Primary CNS Lymphoma
  12. Primary CNS Lymphoma: Salvage Therapy in Routine Practice
  13. Primary CNS Lymphoma: New Targets, New Drugs
  14. Primary CNS Lymphoma: New Strategies for the Old Problem of the Blood-Brain Barrier
  15. Primary CNS Lymphoma: Ongoing Clinical Trials and Goals for Future Studies
  16. Primary CNS Lymphoma: Iatrogenic Neurotoxicity and Other Sequels
  17. Primary vitroretineal lymphoma
  18. Secondary CNS lymphoma

Disclosure:
The special series “Central Nervous System Lymphomas” was commissioned by the editorial office, Annals of Lymphoma without any sponsorship or funding. Andrés J. M. Ferreri and Maurilio Ponzoni are serving as the unpaid Guest Editors for the series.